US Market News
4週前
Mobile-health Network Solutions Enters into Non-Binding Strategic Memorandum to Facilitate Up to US$100 Million in Private Equity Funding for AI-Powered Healthcare ExpansionMay 13, 2026 9:17 AM
NewsfileSingapore, Singapore--(Newsfile Corp. - May 13, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced that it has entered into a Letter of Memorandum with White Group Pte. Ltd. (Singapore) ("White Group") outlining a strategic collaboration to facilitate private equity funding of up to US$100 million to support MNDR's AI-powered healthcare expansion and digital health infrastructure initiatives.Under the memorandum, White Group has committed to identifying and facilitating a U.S.-based private equity fund to partner with MNDR. The contemplated funding is intended to support the initial launch and long-term scaling of MNDR's advanced healthcare technology operations. Any investment arising from this process would be subject to customary reviews, approvals, and applicable regulatory requirements. Focus on Advanced Sports Health and Digital CareProceeds from any funds raised through the private equity facilitation are designated exclusively for MNDR's healthcare technology initiatives. These include the development and delivery of sports health physiotherapy and treatment programs, as well as the support of male and female athletes competing at World Championship-level sporting events.Leadership Commentary"MNDR, being the largest telehealth platform in Singapore, is now bringing sports health into its ecosystem," said Peh Chin Hua, Chairman of White Group Pte. Ltd. "This expansion will not only enhance athlete care but also increase its presence on the world stage."Dr. Siaw Tung Yeng, Co-CEO of Mobile-health Network Solutions, added that the partnership represents "a pivotal step in advancing AI-powered healthcare. By integrating sports health and physiotherapy into our platform, we are creating a holistic digital health solution that empowers both everyday patients and elite athletes worldwide."Proposed Facilitation StructureThe memorandum outlines a proposed facilitation fee structure whereby, upon each drawdown of funds (up to an aggregate of US$100 million), MNDR would issue a facilitation fee to the White Group, payable either:entirely in shares amounting to 5% of the drawn capital, ora combination of 2.5% in shares and 2.5% in USD cash.Any shares issued under the facilitation fee would be based on the prevailing market price on each subsequent drawdown date.Indicative TimelineAs part of the execution roadmap, White Group plans to present a suitable private equity fund candidate to the MNDR Board of Directors for review within approximately 60 days, with an indicative target of July 2026. The parties have also acknowledged the importance of meeting applicable U.S. SEC disclosure requirements in connection with any potential transaction. Non-Binding UnderstandingThe Letter of Memorandum is non-binding and reflects the parties' intent to explore a collaborative pathway to strengthen MNDR's capital base and accelerate its mission in AI-driven global healthcare solutions.About White Group Pte. Ltd.White Group Pte. Ltd. is a privately owned boutique investment and development firm based in Singapore, established in 2005. The group focuses on investing in and managing businesses that create positive impact for people and society by addressing real-world challenges through innovative and practical solutions.White Group partners with purpose-driven companies and brands that seek to deliver tangible benefits to their communities. Its investment approach emphasizes long-term economic development and sustainable growth across sectors such as technology, healthcare, and housing, leveraging innovation to drive meaningful outcomes.With strategic interests primarily in China and Southeast Asia, White Group acquires, invests in, and manages businesses operating in areas including real estate, technology, and healthcare. The group's investments are guided by a commitment to building enduring value for partners while contributing to sustainable and inclusive growth.About Mobile-health Network SolutionsMobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human-through technology. For more information, please visit our website.Forward-Looking StatementsCertain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's advancement into sports health, the Company's goals and future activity, including continued development of proprietary and AI-driven technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.For media inquiries, please contact:Mobile-health Network Solutions Investor Relations Contact:2 Venture Drive, #07-08 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.comInvestor Relations Inquiries:Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: ir@skylineccg.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/297313 Original: Mobile-health Network Solutions Enters into Non-Binding Strategic Memorandum to Facilitate Up to US$100 Million in Private Equity Funding for AI-Powered Healthcare Expansion
US Market News
1月前
Mobile-health Network Solutions Enters into Non-Binding US$119 Million Strategic Framework with Hector Capital to Acquire BIMA and M&M Helix, Accelerating AI-powered Healthcare Expansion across Asia and AfricaMay 4, 2026 9:16 AM
NewsfileSingapore, Singapore--(Newsfile Corp. - May 4, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced the signing of a non-binding Strategic Cooperation Framework Memorandum of Understanding ("MOU") with Hector Capital Holdings Pte. Ltd. ("Hector Capital"). Under the framework, Hector Capital will invest up to US$119 million into MNDR to support the acquisition of majority shareholdings in MILVIK Singapore Pte. Ltd. ("BIMA"), a healthcare platform operating in Asia and Africa, and M&M Helix Pte. Ltd. ("MM Helix"), a healthcare technology firm offering an AI-powered telemedicine and patient care platform.This strategic partnership marks a significant milestone in MNDR's mission to expand its portfolio of AI-powered healthcare solutions across Asia and Africa.Transaction HighlightsCapital Investment: Hector Capital to invest up to US$119 million in MNDR, with the funding structure to be finalized in the definitive agreements, which may include a combination of equity subscription, convertible instruments, and/or other financial instruments. Proceeds will be applied toward the acquisitions and for general corporate and operational purposes.Acquisitions: MNDR to acquire majority stakes in BIMA and MM Helix, integrating them as subsidiaries.Independent Valuation: Consideration for the acquisitions will be consistent with an independent valuation of BIMA and MM Helix to be commissioned and agreed to by the parties prior to execution of the definitive agreements, and remains subject to regulatory approvals under applicable Nasdaq listing rules and Singapore law.About the TargetsM&M Helix Pte. Ltd.: A Singapore-based digital healthcare technology firm offering an AI-powered telemedicine and patient care platform. MM Helix recently expanded its capabilities through the acquisition of Hyderabad-based health-tech firm Zibew, operator of DigitalRx.io, enabling a unified system for clinic and pharmacy workflows.MILVIK BIMA: Founded in 2010, BIMA is a pioneer in democratising healthcare in emerging markets. Its platform provides affordable access to telemedicine, specialist care, health screening, personalized health programs, medicine delivery, laboratory testing, and insurance. Operating across Asia and Africa, BIMA serves millions of customers and is committed to making high-quality healthcare accessible to all.Strategic ValueBy combining MNDR's Nasdaq listing, market access, and operational expertise with Hector Capital's investment, ongoing strategic advisory support, and introductions to relevant business networks, the partnership will:Accelerate growth of BIMA and MM Helix through expanded digital health offerings.Enhance efficiency by leveraging MNDR's AI-driven tele-consultation and workflow automation.Broaden access to affordable healthcare across Asia and Africa.Dr. Siaw Tung Yeng, Co-CEO of MNDR, commented, "This framework sets the stage for transformative growth. By integrating BIMA's healthcare ecosystem and MM Helix's AI-powered platform into MNDR, we are building a scalable, affordable healthcare network that empowers millions of families across emerging markets."Vikash, representing Hector Capital Holdings, added, "Our investment underscores confidence in MNDR's vision. Together, we will unlock synergies that drive profitability, reduce costs through AI, and expand access to healthcare globally."The MOU is strictly non-binding in its entirety and serves as the basis for negotiating definitive agreements, including an Investment Agreement and Share Purchase Agreements. Completion remains subject to MNDR's full legal, financial, and operational due diligence on BIMA and MM Helix, independent valuation, and receipt of all necessary regulatory approvals, including those required under applicable Nasdaq listing rules and Singapore law.About Hector Capital HoldingsHector Capital Holdings Pte. Ltd. is a Singapore-based investment firm with substantial indirect and beneficial shareholdings in regulated fund management entities VPAM and Brown Capital, operating across multiple jurisdictions. The firm specializes in strategic investments that combine capital deployment with operational value-add, supporting portfolio companies in scaling across Asia and beyond.Through majority ownership interests in MILVIK Singapore Pte. Ltd. (BIMA) and M&M Helix Pte. Ltd., Hector Capital has built a strong presence in the digital healthcare sector. Its investment philosophy emphasizes:Long-term growth through technology-driven healthcare solutions.Cross-border structuring to enable expansion into emerging markets.Strategic partnerships that leverage both financial strength and advisory expertise.By partnering with MNDR, Hector Capital is reinforcing its commitment to democratizing healthcare access and accelerating the adoption of AI-powered platforms that improve patient outcomes and operational efficiency.About Mobile-health Network SolutionsMobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human through technology. For more information, please visit our website.Forward-Looking StatementsCertain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's transition to an asset-light platform, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.For media inquiries, please contact:Mobile-health Network Solutions Investor Relations Contact:2 Venture Drive, #07-08 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.comInvestor Relations Inquiries:Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: ir@skylineccg.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/295749
Original: Mobile-health Network Solutions Enters into Non-Binding US$119 Million Strategic Framework with Hector Capital to Acquire BIMA and M&M Helix, Accelerating AI-powered Healthcare Expansion across Asia and Africa
US Market News
1月前
Mobile-health Network Solutions and Dato' Stanley Ling Announce Strategic US$126 Million Investment to Build Phased 60 MW AI Data Center CampusApril 28, 2026 9:36 AM
NewsfileSingapore, Singapore--(Newsfile Corp. - April 28, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced the execution of a definitive Securities Purchase Agreement ("SPA") with Dato' Stanley Ling (Ling Tiung Leng) to fund the Company's expansion into AI-driven digital infrastructure. Under the terms of the SPA, Dato' Stanley Ling has agreed to an aggregate capital injection of MYR 500 million (approximately US$126 million) into the Company. This investment is specifically earmarked for the construction and operation of a 60 MW AI Data Center campus in Sarawak, Malaysia, managed by PP GRID SDN. BHD.The capital injection will be conducted in staged tranches, with MNDR issuing Class A ordinary shares for each funding round. In total, MNDR will issue Mr. Ling nine million Class A shares, valued at US14.10 per share. Upon full completion of the investment, Mr. Ling will hold a 65% equity stake in MNDR. There will be a 180-day lock-up on all issued shares.This partnership updates a strategic framework established in late 2025 to reflect a new funding structure for AI infrastructure projects in Sarawak. MNDR will execute a phased, milestone-driven build, delivering an initial 20-30 MW of capacity in Phase 1 to support anchor customers and early hyperscale AI workloads, then expanding to the full 60 MW campus in Phase 2 as contracted demand materializes. Each funding tranche is tied to permitting, construction, and commercial milestones to align capital deployment with demand. Initial commercial operations for Phase 1 are targeted to begin in 2027.The transaction combines MNDR's status as a Nasdaq-listed technology innovator with Mr. Ling's specialized assets in the digital infrastructure sector. The transaction pairs MNDR's AI health platform with Mr. Ling's digital infrastructure capabilities to accelerate time-to-market, improve data sovereignty, and lower AI compute costs for MNDR services across Southeast Asia and beyond.While the investment results in Mr. Ling owning a majority economic stake, MNDR founders will retain majority voting control through Class B shares, preserving strategic continuity.Transaction DetailsPurchase Price: The Securities are priced at US$14.10 per share.Total Shares: Approximately 9 million Class A Ordinary Shares will be issued upon full subscription.Use of Proceeds: Exclusively for the construction of AI Data Centers, including all related infrastructure and equipment.Lock-Up Period: Issued shares are subject to a 180-day lock-up restriction from the date of their respective issuance.Siaw Tung Yeng, Co-CEO, Mobile-health Network Solutions, stated, "We structured this transaction to secure the land, licenses, and capital needed to build a world-class AI data center campus while protecting long-term shareholder value. The phased approach ties funding to clear milestones and positions MNDR to begin commercial operations in 2027."Mr. Ling added, "This investment reflects confidence in MNDR's technology and market position. By combining local infrastructure with MNDR's AI capabilities, we aim to accelerate commercial operations and create durable value for all stakeholders."About Mobile-health Network SolutionsMobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human - through technology. For more information, please visit our website.Forward-Looking StatementsCertain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's transition to an asset-light platform, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.For media inquiries, please contact:Mobile-health Network Solutions Investor Relations Contact:2 Venture Drive, #07-08 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.comInvestor Relations Inquiries:Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: ir@skylineccg.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/294568
Original: Mobile-health Network Solutions and Dato' Stanley Ling Announce Strategic US$126 Million Investment to Build Phased 60 MW AI Data Center Campus
US Market News
2月前
Mobile-health Network Solutions Announces Acquisition of Additional 35MW AI Data Centre Capacity, Expanding Total Secured Capacity to 60MWApril 24, 2026 9:32 AM
NewsfileSingapore, Singapore--(Newsfile Corp. - April 24, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company") today announced that it has secured an additional 35 megawatts (MW) of high-density artificial intelligence (AI) data centre capacity through its subsidiary PP GRID SDN. BHD. (PPG). With this latest acquisition, a total of 60MW of AI data centre capacity is now secured under the PPG platform.This newly secured 35MW capacity builds upon the initial 25MW AI data centre currently under development in Sarawak, Malaysia. Site cleaning works for the first 25MW are already underway, with construction preparation activities in progress. The Company expects site development and major construction activities for this initial phase to be substantially completed by the end of this year.MNDR noted strong global interest in its AI data centre offerings, with significant inbound demand from customers around the world seeking to reserve capacity within the first 25MW facility. Driven by this demand momentum, the Group estimates that the initial 25MW data centre development will be structurally completed in the end of 2026, in line with current development schedules."With demand for high-density AI computing capacity accelerating worldwide, we are extremely encouraged by the strong interest we are seeing for our first 25MW facility," said Dr Siaw Tung Yeng, CEO of MNDR. "The acquisition of an additional 35MW meaningfully strengthens our platform and positions us to meet growing global demand for scalable, enterprise-grade AI infrastructure."The Company anticipates that the first 25MW data centre will be operationally ready to commence commercial operations in 2027, subject to construction progress, regulatory approvals, and commissioning milestones, in accordance with the current project schedule.MNDR believes that its expanding AI data centre portfolio provides a strong foundation to support long-term growth, enabling the Company to serve rising global demand for AI compute infrastructure across healthcare, enterprise AI, and advanced digital services.About Mobile-health Network SolutionsMobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human - through technology. For more information, please visit our website.Forward-Looking StatementsCertain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's transition to an asset-light platform, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.For media inquiries, please contact:Mobile-health Network Solutions Investor Relations Contact:2 Venture Drive, #07-08 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.comInvestor Relations Inquiries:Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: ir@skylineccg.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/294126
Original: Mobile-health Network Solutions Announces Acquisition of Additional 35MW AI Data Centre Capacity, Expanding Total Secured Capacity to 60MW
US Market News
3月前
Mobile-health Network Solutions Announces Updated MOU for Acquisition of Malaysian AI Data CentersMarch 20, 2026 2:22 PM
NewsfileSingapore, Singapore--(Newsfile Corp. - March 20, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform today announced the signing of a Strategic Cooperation Memorandum of Understanding ("Strategic MOU") dated March 15, 2026. This agreement updates the framework established on November 19, 2025, for the acquisition of PP GRID SDN. BHD. ("PPG") and its development of high-density artificial intelligence (AI) data centers in Sarawak, Malaysia.According to the updated Strategic Cooperation MOU, signed on March 15, 2026, with PPG's sole shareholder, Mr. Dato' Ling Tiung Leng (Stanley Ling), MNDR will acquire 100 percent of PPG, including all AI data center assets, from Mr. Ling. In connection with this acquisition, Mr. Ling will facilitate a capital injection of MYR500 million (about US$127 million) to be utilized for the construction of these data centers. In exchange for the PPG assets and the MYR500 million capital injection, Mr. Ling shall receive a 65 percent equity stake in MNDR. The existing MNDR founders will retain majority voting control through their Class B shares. As part of the transaction, MNDR will independently raise at least US$100 million to finance the future data center development and add value to the merger.The Strategic Cooperation MOU is non-binding and subject to definitive agreement.This Strategic Cooperation MOU served as the critical update to reflect current restructuring and funding needs. While the MOUs established the "ProjectCo" framework and broad equity swap terms, they led directly to the definitive Sale and Purchase Agreement (SPA) executed on March 16, 2026."This updated MOU framework better positions MNDR to secure critical AI computing capacity," said Mobile-health Network Solutions Co-CEO Dr. Siaw Tung Yeng. "We believe this acquisition will provide the linchpin for our global expansion, allowing us to reduce long-term costs for our AI-powered health ecosystem while launching new services like Token as a Service (TaaS) and Healthcare Platform as a Service (APaaS)."Mr. Ling added, "This revised agreement advances our shared vision to scale AI data center capacity across our region. By contributing these assets to a consolidated platform with MNDR, we can accelerate development timelines and attract the institutional capital necessary for high-density compute expansion."As stipulated in the original MOU signed last November, PPG remains responsible for securing all licenses, permits, approvals, and land rights necessary to construct and operate the data centers and related infrastructure, with MNDR retaining majority voting control post-transaction. The updated MOU is subject to customary conditions precedent, including an independent valuation by a mutually agreed valuer to confirm the appropriateness of the share allocation. Completion is also subject to satisfactory legal and financial due diligence, regulatory approvals, and the execution of a Definitive Share Purchase Agreement (SPA).About Mobile-health Network SolutionsMobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human - through technology. For more information, please visit our website.Forward-Looking StatementsCertain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's transition to an asset-light platform, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.For media inquiries, please contact:Mobile-health Network Solutions Investor Relations Contact:2 Venture Drive, #07-08 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.comInvestor Relations Inquiries:Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: ir@skylineccg.comGushengtang Investor Relations Contact:Units 01-04, 36 Floor, Lifeng Centre, No. 761 Dongfeng East Road,
Yuexiu District, Guangzhou, PRC
E-mail: ir@360gst.com To view the source version of this press release, please visit https://www.newsfilecorp.com/release/289402
Original: Mobile-health Network Solutions Announces Updated MOU for Acquisition of Malaysian AI Data Centers
US Market News
3月前
Mobile-health Network Solutions Enters Definitive Agreement to Acquire PPG and Kuching Data Center AssetMarch 20, 2026 2:29 PM
NewsfileSingapore, Singapore--(Newsfile Corp. - March 20, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform, today announced that, on March 16, 2026, it entered into a definitive Sale and Purchase Agreement ("SPA") to acquire 100% of the issued share capital of PP Grid Sdn. Bhd. ("PPG") from Dato' Ling Tiung Leng (Stanley Ling). Strategic Acquisition StructureThis definitive agreement marks the formal execution of the strategic roadmap established by the Company's Memorandum of Understanding (MOU) dated November 19, 2025, and the Strategic Cooperation MOU dated March 15, 2026.Under the terms of the SPA, MNDR will acquire PPG through a Cayman Islands Special Purpose Vehicle (SPV). PPG will serve as the primary holding vehicle for a minimum 96.5% equity interest in IRIX Properties Sdn. Bhd., which holds the legal and beneficial title to Lot 728, Block 3, Salak Land District (the "Kuching Land"). This site is designated for the development and construction of a 25 MW AI-optimized data center.Key Transaction Terms and RelationshipConsideration: The purchase consideration is US$1,500,000, satisfied by the conversion of the refundable deposit previously rendered by MNDR under the November 2025 MOU.Milestone Progression: This SPA transitions the project from the conceptual "ProjectCo" framework mentioned in earlier MOUs to a definitive asset-backed acquisition of PPG and IRIX Properties.Conditions Precedent: Completion is subject to the Vendor securing 96.5% of IRIX Shares, obtaining all necessary AI data center permits, and receiving regulatory clearances for Malaysian foreign ownership restrictions.Clawback Protection: The agreement includes a clawback mechanism where the Vendor must repay the consideration if warranties are breached or the transfer of IRIX/Kuching Land fails.Operational Integration: Dato' Stanley Ling will provide post-completion assistance for 12 months to support integration and the development of the Kuching Land."We are thrilled to enter into this definitive agreement," said MNDR Co-CEO Dr. Siaw Tung Yeng. "This represents a major milestone in our strategic evolution. Having successfully concluded the acquisition framework for the Kuching AI Data Center, we are working closely with Dato' Stanley Ling to ensure this infrastructure meets our internal AI processing demands while providing high-density capacity for third-party users. This transforms MHNS into a leading AI-powered health and technology ecosystem."Mr. Ling added, "My decision to integrate PPG into the MNDR AI ecosystem is rooted in deep confidence in our common mission. We are not just building a facility; we are building the engine that will power the future of accessible, AI-humanized healthcare on a global scale."The ultimate commercial objective remains the listing of the Cayman SPV on a recognized stock exchange to fund ongoing AI data center infrastructure development.Completion of the acquisition pursuant to the SPA remains subject to customary closing conditions. MNDR will provide further updates upon this completion.About Mobile-health Network SolutionsMobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human-through technology. For more information, please visit https://investors.manadr.com/.Forward-Looking StatementsCertain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.For media inquiries, please contact:Mobile-health Network Solutions Investor Relations Contact:2 Venture Drive, #07-06/07 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.comInvestor Relations Inquiries:Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: info@skylineccg.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/289403
Original: Mobile-health Network Solutions Enters Definitive Agreement to Acquire PPG and Kuching Data Center Asset
US Market News
3月前
Mobile-health Network Solutions Reports Improved Gross Margin and Cash Position, Reduced Operating Expenses, in H1 FY2026March 12, 2026 8:30 AM
NewsfileSingapore, Singapore--(Newsfile Corp. - March 12, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading AI HealthTech platform, today announced that, for the first six months of fiscal 2026 ended December 31, 2025, the Company achieved significant improvements in its gross margin and cash position while slashing its total operating expenses and net loss.Gross margin for the first half of fiscal 2026 was 20.1 percent, compared with 14.8 percent for the first half of fiscal 2025. This improvement was mainly the result of a 13.8 percent reduction in cost of revenue, which led to a 25.3 percent increase in gross profit compared to the first half of fiscal 2025. Net cash and cash equivalents at December 31, 2025, rose to $3.48 million, compared with $1.03 million at June 30, 2025. This increase, driven by operational efficiency gains and fundraising, is expected to help facilitate continued investment in AI and selective growth initiatives.Total operating expenses for 1H FY 2026 were $1.67 million, a 29.9 percent reduction compared with $2.38 million in the year-ago period. This improvement was primarily driven by the accelerated deployment of AI-enabled scheduling, predictive maintenance, and automated administrative workflows, which reduced salaries and benefits and other operating costs. The Company's net loss for the first six months of fiscal 2026 was $0.86 million, a 48.2 percent decrease from the net loss of $1.66 million sustained in the first half of fiscal 2025. This improvement was mainly due to the Company's reduction in total operating expenses."We are excited about the progress we have made in the first half of fiscal 2026," said the Chief Executive Officer, Dr. Siaw Tung Yeng, "By embedding AI into our core operations, we have achieved significant savings and better operating results while preserving the quality of our services." Going forward, said Dr. Siaw, the Company's strategic priorities will include:Continue AI deployment. Expand predictive maintenance, intelligent rostering, automated documentation, and analytics across additional contracts to drive further cost savings;Protect and improve service quality. Combine automation with targeted employee upskilling to deliver higher-value service to customers;Maintain disciplined capital management. Preserve liquidity while prioritizing high-ROI AI projects and scalable SaaS initiatives; andReinvest selectively. Allocate a portion of the cost savings to sales expansion, product enhancements, and adoption of Otter.SG, an AI-native Clinic Operating System, unifying clinical, operational, and financial workflows and helping accelerate the Company's transition to an asset-light, software-enabled model.Financial snapshot (six months ended December 31, 2025; unaudited)Revenue: US$3,948,768Gross profit: US$795,303Total operating expenses: US$1,672,590Net loss: US$858,417Cash and cash equivalents: US$3,479,487Net tangible assets (NTA): US$8,326,619NTA per share: US$2.61 (rounded)About Mobile-health Network SolutionsMobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human - through technology. For more information, please visit our website.Forward-Looking StatementsCertain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's transition to an asset-light platform, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.For media inquiries, please contact:Mobile-health Network Solutions Investor Relations Contact:2 Venture Drive, #07-08 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.comInvestor Relations Inquiries:Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: ir@skylineccg.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/288253
Original: Mobile-health Network Solutions Reports Improved Gross Margin and Cash Position, Reduced Operating Expenses, in H1 FY2026
US Market News
3月前
Mobile-health Network Solutions and Medpod Sign MOU to Advance AI-Driven, High-Fidelity Global HealthcareMarch 6, 2026 8:52 AM
NewsfileSingapore, Singapore--(Newsfile Corp. - March 6, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, and Medpod Inc., a U.S.-based innovator in high-fidelity telediagnostics software and infrastructure, today announced the signing of a Memorandum of Understanding (MOU) outlining a strategic partnership to jointly expand intelligent, clinically robust healthcare access across global markets.Under the collaboration, MNDR's AI-powered digital health ecosystem would integrate with Medpod's telediagnostics infrastructure to enhance remote clinical delivery across Southeast Asia, Africa, and other emerging regions. In parallel, MNDR's advanced AI capabilities would be introduced into Medpod-supported healthcare networks, reinforcing both companies' shared mission to modernize healthcare delivery worldwide.The partnership would focus on:Integration of Medpod's diagnostic infrastructure with MNDR's AI-driven platform to enable higher-fidelity remote care;Coordinated deployment in underserved and infrastructure-limited markets;Regulatory enablement and localization for international expansion; andStrategic co-marketing and regional rollout initiatives."This partnership is a natural alignment of vision and capability," said Dr. Siaw Tung Yeng, founder and co-CEO of MNDR. "We believe that 85% of face-to-face consultations can be virtualized. With Medpod's hardware and Telediagnostic Software Ecosystem and our AI-driven platform, we're accelerating this process and bringing the future of decentralized, affordable care closer.""The next generation of healthcare AI cannot be built on low-fidelity inputs. It requires structured, clinically validated diagnostic data — ground truth. Since its inception, Medpod has focused on generating that high-fidelity clinical data layer, enabling intelligent systems to operate with real medical precision," said Jack Tawil, CEO of Medpod. "MNDR is building a powerful AI-driven healthcare brain. Medpod provides the diagnostic senses that allow that brain to see, hear, measure, and understand."Mr. Tawil further addressed the broader global healthcare challenge:"We do not have a global provider shortage — we have a distribution problem," said Tawil. "Medical expertise exists around the world, but it is unevenly deployed and constrained by geography and infrastructure. By combining MNDR's AI-enabled care network with Medpod's mobile diagnostic infrastructure, we are helping redistribute clinical capacity globally and break down both the literal and figurative walls that have held healthcare back for decades."Medpod's flagship innovations, such as the MobileDoc, are award-winning, patented pieces of mobile medical technology — effectively a full telediagnostics cart engineered into a carry-on suitcase — designed to deliver clinically meaningful remote examinations wherever care is needed. The companies believe that innovation developed through international deployments may further enhance Medpod's global ecosystem and strengthen MNDR's AI-enabled clinical workflows across all markets served.Both parties expect the MOU to progress to a definitive agreement in the near future, followed by initial pilot deployments in select regions prior to broader expansion."This is more than a partnership," Dr. Siaw added. "It represents an inflection point in how intelligent healthcare infrastructure is deployed at a global scale."About Mobile-health Network SolutionsMobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human — through technology. For more information, please visit our website.About MedpodMedpod Inc. is a U.S.-based healthcare technology company building a comprehensive Global Telediagnostics Ecosystem designed to enable high-fidelity, infrastructure-independent care delivery.At the core of its ecosystem is MobileDoc, an internationally recognized, award-winning, and patented mobile medical technology platform engineered to deliver structured, clinically validated diagnostic exams beyond traditional clinical settings. Medpod's infrastructure supports scalable healthcare deployment across the United States and expanding markets in Africa, Latin America, and Asia.Working alongside global technology and healthcare leaders, including Intel, Amdocs, Midmark, HORIBA, and Baxter, Medpod is advancing next-generation medical infrastructure designed to support intelligent, AI-enabled healthcare systems worldwide.For more information, please visit www.medpodhealth.com.Forward-Looking StatementsCertain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the Company's current expectations and beliefs and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements. Factors that may cause actual results to differ materially include, but are not limited to, changes in market conditions, regulatory developments, competitive dynamics, execution risks, and other risks described in the Company's filings with the U.S. Securities and Exchange Commission. Any forward-looking statements speak only as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statements, except as required by law.ContactsMobile-health Network Solutions Investor Relations:
2 Venture Drive, #07-06/07 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.comInvestor Relations Inquiries:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: ir@skylineccg.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/286489
Original: Mobile-health Network Solutions and Medpod Sign MOU to Advance AI-Driven, High-Fidelity Global Healthcare
tw0122
6月前
2.36 .. Our Public Float as of November 26, 2025 was $8,686,752.50, based on 1,828,790 shares of our common stock issued and outstanding and held by non-affiliates on November 26, 2025, and a price per share of $4.75 as of November 21, 2025, which is a date within 60 days prior to the filing date of this prospectus supplement. As of the date hereof, we have sold securities with an aggregate market value of $2,248,445 pursuant to General Instruction I.B.5 of Form F-3 during the prior 12-month period that ends on and includes the date hereof. This prospectus supplement should be read in conjunction with the Prior Prospectus, including all supplements thereto and documents incorporated by reference therein, and is qualified by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the Prior Prospectus. This prospectus supplement is not complete without and may only be delivered or utilized in connection with, the Prior Prospectus and any future amendments or supplements thereto. Our Class A Ordinary Shares are listed on The Nasdaq Capital Market (“Nasdaq”) under the symbol “MNDR.” The last reported sale price of our Class A Ordinary Shares on November 26, 2025, was $2.65 per share.